H-LMEDLDR^-OH

Rif. 3D-PP44325

Informazioni sul prodotto

• Nome: H-LMEDLDR^-OH
• Sinonimi: NH2-Leu-Met-Glu-Asp-Leu-Asp-Arg^-OH

Descrizione

Peptide H-LMEDLDR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LMEDLDR^-OH include the following: Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction S Zimmermann , ML Biniossek, C Maurer - , 2009 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.200900232 Profiling of apoptotic changes in human breast cancer cells using SELDI-TOF mass spectrometry S Leong, R Christopherson , R Baxter - Cellular Physiology and , 2007 - karger.comhttps://karger.com/cpb/article-abstract/20/5/579/207954 Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling LM Orre , M Pernemalm , J Lengqvist - Molecular & Cellular , 2007 - ASBMBhttps://www.mcponline.org/article/S1535-9476(20)31904-6/fulltext Development of a targeted urine proteome assay for kidney diseases LG Cantley, CM Colangelo , KL Stone - PROTEOMICS , 2016 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201500020 Multiple reaction monitoring assay for pre-eclampsia related calcyclin peptides in formalin fixed paraffin embedded placenta C Güzel, NTC Ursem, LJ Dekker - Journal of proteome , 2011 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr1010795 Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients BR Wei, SB Hoover, MM Ross , W Zhou, F Meani - PLoS , 2009 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007670

• Marchio: Biosynth